UnknownNot Applicable

Sphenopalatine Ganglion Block and Pain Management in Neurosurgery

Italy84 participantsStarted 2021-02-01

Plain-language summary

Post craniotomy pain is defined as headache developed up to 7 days from a craniotomy, not otherwise explained. A moderate to severe pain affects from 60 to 84% of patients. Sphenopalatine ganglion block has been successfully used in patients with chronic or acute headache, facial pain and for transsphenoidal pituitary and endoscopic sinus surgeries. There are evidences that sphenopalatine ganglion block reduces vegetative responses to skull pin closure. This study aim to investigate feasibility and efficacy of sphenopalatine ganglion block in reducing pain after a neurosurgical supratentorial craniotomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * supratentorial craniotomy Exclusion Criteria: * prior craniofacial pain syndrome * drug assumption: pain-killers (chronic), antiepileptic

What they're measuring

Numerical Rating Scale

Timeframe: Immediately post-op

Numerical Rating Scale

Timeframe: 1° days post-op

Numerical Rating Scale

Timeframe: 2° days post-op

Numerical Rating Scale

Timeframe: 3° days post-op

Numerical Rating Scale

Timeframe: 4° days post-op

Numerical Rating Scale

Timeframe: 30° days post-op

Numerical Rating Scale

Timeframe: 60° days post-op

Numerical Rating Scale

Timeframe: 180° days post-op

Visual Analogic Scale

Timeframe: Immediately post-op

Trial details

NCT IDNCT05136625

SponsorUniversity Hospital of Ferrara

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-31

Contact for this trial

Alba Scerrati, MD

3381402733 scrlba@unife.it

View on ClinicalTrials.gov More Post Operative Pain trials